← Back to Dashboard

Tipranavir

Protease inhibitor

2D Structure

Loading structure...

3D Structure

Loading 3D structure...

Chemical Identifiers

CCCC1(CC(=C(C(=O)O1)C(CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)…
SUJUHGSWHZTSEU-FYBSXPHGSA-N
ClinicalTrials.govPubMed

Clinical Development by Virus5

FDA approved
Preclinical
Phase 2positive
Phase 3positive
Approved
FDA
Approval ref: AntiviralDb
Human immunodeficiency virus 1
HIV-1
Target: Viral protease
FDA approved
Preclinical
Phase 2positive
Phase 3positive
Approved
FDA
DB00932
Tick-borne encephalitis virus
TBEV
Target: Viral protease
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:32326119
West Nile virus
WNV
Target: Viral protease
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:32326119
Zika virus
ZIKV
Target: Viral protease
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:32326119